SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882095-18-000029
Filing Date
2018-11-06
Accepted
2018-11-06 16:14:13
Documents
87
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q q318form10-q.htm 10-Q 2147201
2 EXHIBIT 10.28 gildq32018ex1028.htm EX-10.28 29643
3 CEO CERTIFICATION gildq32018ex311.htm EX-31.1 7997
4 CFO CERTIFICATION gildq32018ex312.htm EX-31.2 7966
5 SECTION 906 CERTIFICATIONS gildq32018ex321.htm EX-32.1 6189
  Complete submission text file 0000882095-18-000029.txt   12000440

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gild-20180930.xml EX-101.INS 3694535
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20180930.xsd EX-101.SCH 61590
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gild-20180930_cal.xml EX-101.CAL 107928
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gild-20180930_def.xml EX-101.DEF 257263
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20180930_lab.xml EX-101.LAB 746068
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20180930_pre.xml EX-101.PRE 436830
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19731 | Film No.: 181163125
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1